139 related articles for article (PubMed ID: 597565)
1. Blood platelet and "extra-platelet" serotonin in some myeloproliferative disorders.
Culebras Poza JM; Launay JM; Briere J; Dreux C
Biomedicine; 1977 Nov; 27(8):300-3. PubMed ID: 597565
[TBL] [Abstract][Full Text] [Related]
2. Blood platelet calcium content and aggregation behaviour in myeloproliferative disorders and secondary thrombocytosis.
Mindner K; Ostermann G; Hochhaus A; Höche D; Till U
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):461-4. PubMed ID: 2465953
[TBL] [Abstract][Full Text] [Related]
3. Reduced amounts of platelet 5-hydroxytryptamine in myeloproliferative disorders.
Okamoto S; Nishimura J; Motomura S; Ibayashi H
Nihon Ketsueki Gakkai Zasshi; 1982 Feb; 45(1):142-5. PubMed ID: 7113610
[No Abstract] [Full Text] [Related]
4. Platelets in myeloproliferative disorders. II. Serotonin uptake and storage: correlations with mepacrine labelled dense bodies and with platelet density.
Caranobe C; Sie P; Nouvel C; Laurent G; Pris J; Boneu B
Scand J Haematol; 1980 Oct; 25(4):289-95. PubMed ID: 7209398
[TBL] [Abstract][Full Text] [Related]
5. Reticulated platelets are increased in chronic myeloproliferative disorders, pure erythrocytosis, reactive thrombocytosis and prior to hematopoietic reconstitution after intensive chemotherapy.
Ryningen A; Apelseth T; Hausken T; Bruserud Ø
Platelets; 2006 Aug; 17(5):296-302. PubMed ID: 16928601
[TBL] [Abstract][Full Text] [Related]
6. Effect of aspirin on platelet 5-hydroxytryptamine and beta-thromboglobulin plasma levels in patients with myeloproliferative diseases.
Viero P; Cortelazzo S; Bassan R; Barbui T
Thromb Haemost; 1982 Oct; 48(2):125-6. PubMed ID: 6184841
[TBL] [Abstract][Full Text] [Related]
7. Abnormal platelet serotonin uptake and binding sites in myeloproliferative disorders.
Caranobe C; Sié P; Fernandez F; Pris J; Moatti S; Boneu B
Thromb Haemost; 1984 Jul; 51(3):349-53. PubMed ID: 6593892
[TBL] [Abstract][Full Text] [Related]
8. Correlation between prolonged bleeding time and depletion of platelet dense granule ADP in patients with myelodysplastic and myeloproliferative disorders.
Malpass TW; Savage B; Hanson SR; Slichter SJ; Harker LA
J Lab Clin Med; 1984 Jun; 103(6):894-904. PubMed ID: 6233383
[TBL] [Abstract][Full Text] [Related]
9. In vitro platelet aggregation defects in patients with myeloproliferative disorders and high platelet counts: are they laboratory artefacts?
Grignani C; Noris P; Tinelli C; Barosi G; Balduini CL
Platelets; 2009 Mar; 20(2):131-4. PubMed ID: 19235056
[TBL] [Abstract][Full Text] [Related]
10. [Aggregative behavior and calcium content of platelets in thrombocythemia and thrombocytosis].
Hochhaus A; Mindner K; Ostermann G; Höche D
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):765-70. PubMed ID: 1713878
[TBL] [Abstract][Full Text] [Related]
11. Platelet serotonin and plasma prolactin and cortisol in healthy, depressed and schizophrenic women.
Muck-Seler D; Pivac N; Mustapic M; Crncevic Z; Jakovljevic M; Sagud M
Psychiatry Res; 2004 Jul; 127(3):217-26. PubMed ID: 15296821
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of fluorometric assay methods for serotonin in platelets. Plasma and whole blood samples by comparison with GC-MS-SIM Technique.
Mumtaz M; Narasimhachari N; Friedel RO; Pandey GN; Davis JM
Res Commun Chem Pathol Pharmacol; 1982 Apr; 36(1):45-60. PubMed ID: 7079588
[TBL] [Abstract][Full Text] [Related]
13. Platelets in myeloproliferative disorders. I. A comparative evaluation with certain platelet function tests.
Boneu B; Nouvel C; Sie P; Caranobe C; Combes D; Laurent G; Pris J; Bierme R
Scand J Haematol; 1980 Sep; 25(3):214-20. PubMed ID: 7466310
[TBL] [Abstract][Full Text] [Related]
14. [Determination of free serotonin (in the blood plasma) and thrombocyte-bound serotonin by spectrofluorometric method].
Solomonav AP; Larskiĭ EG
Lab Delo; 1973; 2():80-3. PubMed ID: 4128348
[No Abstract] [Full Text] [Related]
15. Platelet membrane fatty acids in thrombocytosis due to myeloproliferative disorders.
Leoncini G; Maresca M; Balestrero F; Benatti U; Armani U; Piana A
Cell Biochem Funct; 1984 Jan; 2(1):23-5. PubMed ID: 6467512
[TBL] [Abstract][Full Text] [Related]
16. [Plasma and platelet serotonin in children with essential headache].
Nicoli L; Mambelli M; Scanabissi E; Franzoni E; Guidi M; Gualandi S; Corsini F
Boll Soc Ital Biol Sper; 1983 Aug; 59(8):1053-8. PubMed ID: 6626340
[TBL] [Abstract][Full Text] [Related]
17. [Selected parameters of blood platelet function in patients with myeloproliferative syndrome].
Zuk E
Ann Acad Med Stetin; 1998; 44():137-54. PubMed ID: 9857536
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous study of platelets and phagocytes in myeloproliferative disorders.
Laharrague PF; Corberand JX; Fillola G; Boneu BP; Pris JF
Biomed Pharmacother; 1984; 38(9-10):462-5. PubMed ID: 6597727
[TBL] [Abstract][Full Text] [Related]
19. [Phospholipids and platelet procoagulant activity in myeloproliferative syndromes].
Martínez E; César J; Navarro JL; Mercado A; Pardo A; García Avello A; García Frade J
Sangre (Barc); 1985; 30(1):22-7. PubMed ID: 4039850
[No Abstract] [Full Text] [Related]
20. Abnormal aggregation and increased size of platelets in myeloproliferative disorders.
Cortelazzo S; Barbui T; Bassan R; Dini E
Thromb Haemost; 1980 Jun; 43(2):127-30. PubMed ID: 7455970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
